The sustained receptor activation achieved by semaglutide produces more pronounced and consistent metabolic effects compared to the pulsatile, meal-related actions of endogenous GLP-1
The mechanism of action is twofold, leading directly to a necessary reduction in caloric intake
Also, like many medications, the body takes time to adjust and acclimate to semaglutide, so it's not as simple as taking a pill and watching the pounds melt away
Quick Answer: Sugar cravings may persist on GLP-1 medications because these drugs primarily address biological hunger mechanisms but don't directly target psychological eating patterns, learned behaviors, or individual variations in brain reward pathways
This means Ozempics weight-loss potential likely falls somewhere between these two trial results, though it remains lower than Mounjaro in equivalent-dose comparisons